Device Trial Radar · NCT05645133
QPlus Pediatric Reference Interval
Last checked: Nov 20, 2026Latest source record: Jun 15, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
93
Actual
Start
Feb 27, 2023
Primary completion
Jun 1, 2023
Study completion Jun 10, 2023
Sponsor
- Lead sponsor
- HemoSonics LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 9, 2022
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, up to 17 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Evaluation of coagulation results reported by the Qplus Quantra System to determine pediatric reference range intervals.
Conditions
- Pediatric ALL
- Healthy
Interventions
Diagnostic TestDevice
Diagnostic device to monitor coagulation properties of a whole blood sample at the point of care
Primary outcomes
What the sponsor says the trial is designed to measure.
- Reference range interval for measurement of clot time (CT) parameterTime frame: Baseline, after access placement before any procedures
- Reference range interval for measurement of clot time (CTH) parameterTime frame: Baseline, after access placement before any procedures
- Reference range interval for measurement of clot stiffness (CS) parameterTime frame: Baseline, after access placement before any procedures
2 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Nicklaus Childrens Hospital
Miami, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.